Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Palmerton Holdings, Inc. is a medical technology holding company primarily known as the parent of Buffalo Filter, a global leader in surgical smoke evacuation. Acquired by CONMED Corporation in 2019 for approximately $365 million, the company specializes in developing and manufacturing advanced technologies that remove hazardous smoke and aerosols generated during laser and electrosurgical procedures. Its product portfolio includes smoke evacuators, filters, and specialized surgical accessories designed to improve operating room safety for both patients and healthcare staff. The company operates out of a significant manufacturing facility in Lancaster, New York, and its technologies are integrated into CONMED's broader general surgery offerings. By providing comprehensive solutions for plume management, Palmerton Holdings helps healthcare facilities comply with safety regulations and protect surgical teams from the risks associated with surgical smoke.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Palmerton Holdings.